NIM
GH icon

NEOS Investment Management’s Guardant Health GH Stock Holding History

NEOS Investment Management’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-8,030
Closed -$820K – 603
2025
Q4 		$820K Sell
8,030
-2,255
-22% -$202K ﹤0.01% 569
2025
Q3 		$643K Sell
10,285
-1,065
-9% -$57.9K ﹤0.01% 561
2025
Q2 		$591K Buy
11,350
+1,190
+12% +$53.1K 0.01% 528
2025
Q1 		$433K Sell
10,160
-25,960
-72% -$1.12M 0.01% 527
2024
Q4 		$1.1M Buy
36,120
+3,553
+11% +$100K 0.03% 393
2024
Q3 		$747K Buy
32,567
+2,165
+7% +$61.3K 0.02% 425
2024
Q2 		$878K Buy
30,402
+8,406
+38% +$196K 0.04% 352
2024
Q1 		$454K Buy
21,996
+6,140
+39% +$132K 0.03% 402
2023
Q4 		$429K Buy
+15,856
New +$416K 0.04% 315

Other funds holding GH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

NEOS Investment Management's GH Position: Q1 2026 in Review

NEOS Investment Management sold out of Guardant Health (GH) in Q1 2026, closing a stake of 8,030 shares — an estimated $820K sold.

NEOS Investment Management first reported a position in GH in Q4 2023 and held it in 9 quarters. The position peaked at $1.1M in Q4 2024. 485 funds tracked by Wall St. Rank hold GH as of Q1 2026.

  • NEOS Investment Management reported no remaining Guardant Health position as of Q1 2026 after selling out during the quarter.
  • NEOS Investment Management sold 8,030 Guardant Health shares in Q1 2026, an estimated $820K.
  • NEOS Investment Management first reported a position in Guardant Health in Q4 2023 and held it in 9 quarters.
  • NEOS Investment Management's Guardant Health position peaked at $1.1M in Q4 2024.
  • 485 funds tracked by Wall St. Rank held Guardant Health as of Q1 2026.

Based on NEOS Investment Management's 13F filing for Q1 2026, filed 15 May 2026.